SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001156175-14-000007
Filing Date
2014-02-10
Accepted
2014-02-10 14:21:33
Documents
1
Group Members
BROOKSIDE CAPITAL PARTNERS FUND, L.P.BROOKSIDE CAPITAL TRADING FUND, L.P.

Document Format Files

Seq Description Document Type Size
1 FILING A SCHEDULE 13G FOR BROOKSIDE CAPITAL MANAGEMENT. Dicerna13G.txt SC 13G 11596
  Complete submission text file 0001156175-14-000007.txt   13210
Mailing Address JOHN HANCOCK TOWER 200 CLARENDON STREET BOSTON MA 02116
Business Address JOHN HANCOCK TOWER 200 CLARENDON STREET BOSTON MA 02116 617-516-2000
BROOKSIDE CAPITAL MANAGEMENT LLC (Filed by) CIK: 0001156175 (see all company filings)

IRS No.: 043517087 | State of Incorp.: DE
Type: SC 13G

Mailing Address 480 ARSENAL ST. BUILDING 1, SUITE 120 WATERTOWN MA 02472
Business Address 480 ARSENAL ST. BUILDING 1, SUITE 120 WATERTOWN MA 02472 617 621 8097
Dicerna Pharmaceuticals Inc (Subject) CIK: 0001399529 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87866 | Film No.: 14587867
SIC: 2834 Pharmaceutical Preparations